Dean Diagnostics and Agena of the United States work together to promote the implementation of precision medical care in China
In recent years, precision medicine has become a trend in medical development. Dean diagnosed the "combination boxing" in the past two years: in November 2017, it cooperated with Danaher Group in the field of mass spectrometry. In April 2018, it cooperated with Roche Group and FMI in the field of precision diagnosis of tumors. On July 4th, he made a heavy blow and joined hands with Agena Bioscience (hereinafter referred to as “Agenaâ€) to make new contributions to the promotion of international advanced diagnosis and treatment technology. Dean Diagnostics announced that it has reached a commercial cooperation agreement with Agena. The two parties will work together to promote the promotion of nucleic acid mass spectrometry technology platform and multiple DNA gene detection diagnostic programs in the Chinese market, and commit to the clinical research and practice of life sciences and precision medicine , and promote precision medical care in China. The final implementation of the plan. Signing ceremony site In this cooperation, Dean Diagnostics Designated Platform will obtain the authorization of Agena's core products in China, and rely on Agena's global leading technology advantages in nucleic acid mass spectrometry platform to cooperate with Dean to diagnose the laboratory network and channel resources in China. “Greater China Nucleic Acid Mass Spectrometry Demonstration Laboratoryâ€, develops and establishes customer resources and expert resources in the fields of genetic diseases, pharmacogenomics, infectious diseases, etc., promotes expert consensus on clinical application guidelines for nucleic acid mass spectrometry diagnostic projects, and forms industry technical application standards. To enhance the distribution and service network capabilities of clinical hospitals, and promote the development of diagnostic techniques, clinical applications and industrialization of genomics. Speech by Mao Xihao, member of the Standing Committee of the CPC Hangzhou Municipal Committee and Secretary of the Yuhang District Party Committee At the launching ceremony of the project, Mao Xihao, member of the Standing Committee of the CPC Hangzhou Municipal Committee and Yuhang District Party Committee, said that Yuhang District will take the biomedical industry as the top priority in the next round of development. Therefore, the launch of the Sino-US Nucleic Acid Mass Spectrometry Project will inject new impetus into domestic R&D and industrialization. The project settled in Yuhang is a great development for the booming Yuhang Economic and Technological Development Zone and even the development of the biomedical industry in Hangzhou. Good. Speech by Su Zhiliang, member of the party group and chief engineer of Zhejiang Food and Drug Administration Su Zhiliang, member of the Party Committee and Chief Engineer of Zhejiang Food and Drug Administration, introduced the excellent situation of medical device approval in the country and Zhejiang Province, and mentioned that the cooperation between Dean and Agena brought international advanced technology and equipment into China. The project encouraged by China Manufacturing 2025 is of great significance for narrowing the gap between China and the international advanced level and improving the level of clinical testing. It is hoped that this cooperation will stand at the global commanding heights from a global perspective and create a first-class international project of quality, management and innovation, and become a sample to lead the development of China's medical device industry. Dean Diagnostics Chairman Chen Haibin delivered a speech Chairman Chen Haibin reviewed the history of Diaan's diagnosis and development, and proposed that the development of Dean must have changed from the era of speed, strength and width to the era of endurance, ability and depth. The future development must be Driven by technological innovation. The premise of precision medicine is accurate diagnosis. The two main technical platforms for precision diagnosis are gene sequencing and biological mass spectrometry. Therefore, Dean has been focusing on the development of precision diagnosis in recent years. The cooperation with Agena and complementary advantages will combine the advantages of Dean's brand, channel, capital and service in China, based on the characteristics of the Chinese market, and promote the transformation of international advanced DNA gene mass spectrometry technology in China. Benefiting patients in China. At the same time, Dean Diagnostics will also maintain its initial heart, create ingenuity, pursue innovation, and aspire to become the leader in the field of precision diagnosis in China, contributing to life science, healthy Hangzhou, and healthy China. Speech by Peter Dansky, President of Agena Global Agena Global President Peter Dansky first introduced his impressive decision-making speed and change in China. He also stated that Agena's mission is to improve clinical decision making by providing advanced and economical diagnostic techniques to enable doctors and their patients to achieve precise care. Dean Diagnostics and Agena have a common strategic vision, consistent values, a nationwide clinical testing service business network and a wealth of clinical diagnostic product sales channels, is an ideal partner for Agena. The two sides will jointly open a new path for improving the medical decisions of millions of Chinese and improving the medical status of China! At the scene, Tian Yaping, director of the Biochemical Department of the Beijing General Hospital of the People's Liberation Army, President of Peter Dansky, Chairman of Chen Haibin, Vice President of Agena, and General Manager of China, Wang Bofei, also discussed the theme of “Digital Nucleic Acid Mass Spectrometry in the Clinical Market of China†and many media. The reporter chatted about the advantages of the technology, the application prospects of China's clinical market, and the benefits and values ​​of society and people. Live media interaction Dean Diagnostics and Agena's cooperation on the introduction and landing of China-US nucleic acid mass spectrometry project in China will make the international frontier mass spectrometry technology no longer far away, and effectively reduce China's medical expenditure, directly benefiting the vast number of ordinary people and becoming China and the United States. A new milestone in the history of mass spectrometry. Ward Nursing System,Ward Nurse Call System,Urgent Nurse Call System,Nurse Call Systems Hunan Eter Medical Co., Ltd. , https://www.eter-tech.com
Medical Ward Nursing System
Features of Ward Nursing System:
1. Act as management center that can be linked to PC with WNS software suitable for hospital, where internal communication is needed and is easy to be operated.
2. The Master Host can support 200 extensions (Included bed extension, door extension, bathroom extension); WNS software can record and check patient information.
3.Nurse Extension can broadcast for ward area.
4.Smart Handle have LED night light.
5.Bath Extension can receive the signals of nurse arriving and ward inspection.
6. Door Extension equipped with multicolour door lamp, can indicate different situation by different colour.
ETR ward nursing system is composed of the integrated host (including operating software), management host, bed extension, smart handle extension, nurse extension, door extension, mobile extension, extra bed extension, bathroom extension, connection extension, corridor display and various extended control devices.